Clincosm LogoSign in Get a demo

Prostate Cancer Metastatic

Showing 26 - 50 of 90
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Prostate Adenocarcinoma, Castration-resistant Prostate Cancer, Prostate Cancer Trial in Boston (Neratinib)

Terminated
  • Metastatic Prostate Adenocarcinoma
  • +3 more
  • Boston, Massachusetts
  • +2 more
Jul 18, 2022

Glioblastoma, Melanoma Stage IV, Melanoma Recurrent Trial in United Kingdom, United States (ST101)

Recruiting
  • Glioblastoma
  • +11 more
  • San Francisco, California
  • +11 more
Jul 13, 2022

Prostate Cancer Metastatic Trial (SABR, no RT)

Not yet recruiting
  • Prostate Cancer Metastatic
  • SABR
  • no RT
  • (no location specified)
Jul 11, 2022

FTT PET/CT in Metastatic Prostate Cancer

Not yet recruiting
  • Prostate Cancer Metastatic
  • Philadelphia, Pennsylvania
    University of Pennsylvania Hospital
Jul 13, 2022

Prostate Cancer, Prostate Cancer Recurrent, Prostate Cancer Metastatic Trial in Leuven (Radiotherapy (SBRT) and/or surgery

Recruiting
  • Prostate Cancer
  • +6 more
  • Radiotherapy (SBRT) and/or surgery (metastasectomy)
  • +2 more
  • Leuven, Belgium
    University Hospitals Leuven
Jun 7, 2022

Prostate Cancer Metastatic, Radiation Therapy, Positron-Emission Tomography Trial in Umeå, Jönköping (stereotactic body

Recruiting
  • Prostate Cancer Metastatic
  • +2 more
  • stereotactic body radiotherapy
  • +2 more
  • Umeå, Umea, Sweden
  • +1 more
May 19, 2022

Prostate Cancer, Prostate Cancer Metastatic, Prostate Cancer Recurrent Trial in Candiolo (Magnetic Resonance Imaging)

Recruiting
  • Prostate Cancer
  • +3 more
  • Magnetic Resonance Imaging
  • Candiolo, Italy
    Fondazione del Piemonte per l'Oncologia
May 17, 2022

Prostate Cancer Metastatic Trial in United States (FOR46)

Active, not recruiting
  • Prostate Cancer Metastatic
  • Los Angeles, California
  • +4 more
May 9, 2022

Non-study Population of Symptomatic mCRPC Patients Treated With

Active, not recruiting
  • Prostate Cancer Metastatic
  • Bone Metastases
  • Blood tests
  • Amsterdam, Netherlands
  • +1 more
Apr 20, 2022

Prostate Cancer With Non-invasive Method Based on DNA

Withdrawn
  • Prostate Cancer
  • +2 more
    • Almaty, Kazakhstan
      Kazakh Institute of Oncology and Radiology
    Apr 13, 2022

    Prostate Cancer Metastatic, Metastasis Trial in Netherlands (Cabazitaxel, Abiraterone, Enzalutamide)

    Completed
    • Prostate Cancer Metastatic
    • Metastasis
    • Alkmaar, Netherlands
    • +18 more
    Apr 14, 2022

    Prostate Cancer Metastatic Trial in Leiden (Enzalutamide, 11C or 18F-Choline PET/CT, Whole body MRI)

    Completed
    • Prostate Cancer Metastatic
    • Leiden, Netherlands
      Leiden University Medical Center
    Apr 6, 2022

    Prostate Cancer Metastatic Trial in Leiden (Enzalutamide, 18-FDG PET/CT, Whole body MRI)

    Completed
    • Prostate Cancer Metastatic
    • Leiden, Netherlands
      Leiden University Medical Center
    Apr 6, 2022

    Prostate Cancer, Prostate Adenocarcinoma, Prostate Tumor Trial (Abiraterone Oral Tablet, Prednisone tablet, Drug Dairy/Log)

    Not yet recruiting
    • Prostate Cancer
    • +3 more
    • Abiraterone Oral Tablet
    • +3 more
    • (no location specified)
    Apr 1, 2022

    Advanced Cancer, Gastric Cancer, Breast Cancer Trial in United States (Minnelide™Capsules)

    Recruiting
    • Advanced Cancer
    • +9 more
    • Birmingham, Alabama
    • +6 more
    Apr 4, 2022

    Prostate Cancer Metastatic Trial in New York (REGN2810, Degarelix, Leuprolide Acetate)

    Recruiting
    • Prostate Cancer Metastatic
    • New York, New York
      Columbia University Irving Medical Center
    Mar 22, 2022

    Prostate Cancer Metastatic, Advanced Breast Cancer, Castration-resistant Prostate Cancer Trial in Denmark, Finland, France

    Active, not recruiting
    • Prostate Cancer Metastatic
    • +3 more
    • Copenhagen, Denmark
    • +3 more
    Mar 23, 2022

    Prostate Cancer Metastatic, Prostate Cancer Trial in Worldwide (ODM-201, Placebo)

    Active, not recruiting
    • Prostate Cancer Metastatic
    • Prostate Cancer
    • Bordeaux, France
    • +31 more
    Mar 18, 2022

    Molecular Profiling in Prostate Cancer

    Recruiting
    • Prostate Cancer Metastatic
    • +4 more
    • Tumor molecular profiling
    • Athens, Greece
      Hellenic Cooperative Oncology Group
    Mar 15, 2022

    Prostatic Tumors, Prostatic Diseases, Prostate Cancer Trial in Portland (68GA PSMA-HBED-CC)

    Approved for marketing
    • Prostatic Neoplasms
    • +4 more
    • 68GA PSMA-HBED-CC
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Mar 11, 2022

    Prostate Cancer, Prostate Adenocarcinoma, Prostate Cancer Metastatic Trial in Ann Arbor (68Ga-PSMA)

    Active, not recruiting
    • Prostate Cancer
    • +3 more
    • Ann Arbor, Michigan
      University of Michigan
    Mar 10, 2022

    Prostate Cancer Metastatic, Castrate Resistant Prostate Cancer, Metastatic Prostate Cancer Trial in San Antonio (High Intensity

    Recruiting
    • Prostate Cancer Metastatic
    • +3 more
    • High Intensity Interval Training
    • San Antonio, Texas
      UT Health San Antonio
    Feb 17, 2022

    Prostate Cancer Metastatic Trial in Spain (Olaparib)

    Active, not recruiting
    • Prostate Cancer Metastatic
    • Santiago De Compostela, A Coruña, Spain
    • +7 more
    Feb 8, 2022

    Prostate Cancer Metastatic, Castration-resistant Prostate Cancer Trial in Worldwide (Docetaxel in Parenteral Dosage Form,

    Completed
    • Prostate Cancer Metastatic
    • Castration-resistant Prostate Cancer
    • Detroit, Michigan
    • +27 more
    Feb 7, 2022

    Prostate Cancer, Prostate Cancer Metastatic, Prostate Cancer Metastatic to Bone Trial in Dallas (68Ga PSMA-11 injection,

    Recruiting
    • Prostate Cancer
    • +2 more
    • 68Ga PSMA-11 injection
    • Positron Emission Tomography/Computed Tomography
    • Dallas, Texas
      UT Southwestern Medical Center
    Feb 3, 2022